Top Story

ATMOSPHERE: Aliskiren fails to benefit patients with HF, diabetes vs. enalapril

May 26, 2016

In patients with diabetes and HF, the direct renin inhibitor aliskiren did not significantly improve outcomes compared with the ACE inhibitor enalapril, according to new data from the ATMOSPHERE trial.

In the overall results, presented in April, aliskiren (Tekturna, Novartis) alone or combined with enalapril did not improve CV mortality or hospitalization for HF compared with enalapril alone.

Meeting News Coverage

Insulin resistance a culprit for non-alcoholic fatty liver disease

May 21, 2016
NEW ORLEANS — The prevalence of nonalcoholic fatty liver disease is high in patients with diabetes, and insulin resistance is a common cause, according to a…
Meeting News Coverage

Despite guideline changes, statin use unchanged or lower in patients with diabetes

May 21, 2016
NEW ORLEANS — The rate of statin use in adults with diabetes has remained steady or declined since 2014, according to findings presented at the National Lipid…
Trial Scorecards

Trial Scorecard: STAMPEDE

Cardiology Today, May 2016
Researchers compared outcomes of intensive medical therapy, Roux-en-Y gastric bypass surgery or sleeve gastrectomy in patients with mild to moderate obesity and type 2…
In the Journals

Healthy diet may reduce hypertension risk in women with gestational diabetes

April 21, 2016
Women with gestational diabetes were 20% less likely to develop hypertension later in life if they maintained a healthy diet, researchers reported in…

Meeting News Coverage

Major bleeding risk low in real-world study of high-risk users of rivaroxaban

April 20, 2016
CHICAGO — A postmarketing study of users with nonvalvular atrial fibrillation taking rivaroxaban confirms that the real-world risk for major…

Meeting News CoverageVideo

VIDEO: PEGASUS-TIMI 54 analysis shows reduced risk for MACE in patients with diabetes

April 7, 2016
CHICAGO — At the American College of Cardiology Scientific Session, Deepak L. Bhatt, MD, MPH, provides investigator insight on a new…

Meeting News Coverage

STAMPEDE: Glycemic benefits of bariatric surgery sustained up to 5 years

April 6, 2016
CHICAGO — Patients with mild to moderate obesity and type 2 diabetes who underwent bariatric surgery had better glycemic control than patients…

Meeting News CoverageVideo

VIDEO: Diabetes may be risk equivalent for PAD, CAS

April 3, 2016
CHICAGO — In this video exclusive, Jeffrey S. Berger, MD, discusses new research on the prevalence of peripheral artery disease and carotid…

In the Journals

CTOs linked to mortality in patients with CAD, diabetes

March 31, 2016
In patients with CAD and diabetes, the presence of chronic total occlusion of coronary arteries was linked to increased mortality in patients…

Alirocumab reduces need for apheresis therapy

March 26, 2016
Sanofi and Regeneron announced positive topline results of from the ODYSSEY ESCAPE trial demonstrating that the addition of alirocumab to weekly or…

In the Journals

No increased heart failure risk with incretin therapies in type 2 diabetes

March 24, 2016
Treatment with incretin-based therapies is not associated with increased risk for heart failure in patients with type 2 diabetes vs. patients taking…


The Patient with Uncontrolled Diabetes at High Risk for a Cardiovascular Event

March 15, 2016 Expires: 3/15/2017
The 2015 AACE guidelines incorporate an integrated consideration of micro- and macrovascular risk (including cardiovascular [CV] risk factors such as…

No commercial support for this activity.

In the Journals

Metabolic syndrome may increase risk for mild cognitive impairment, dementia

March 1, 2016
Metabolic syndrome was associated with elevated incidence of mild cognitive impairment and subsequent progression to dementia, according to study…

More Headlines »
morganatic-roan morganatic-roan